Sherry Aulin
Chief Financial Officer · Xenon Pharmaceuticals Inc.
- 2024
- Dec 19, 2024
- 1
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Sherry Aulin files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Ian Mortimer - $21.42M in XENE purchases and sales in the last 12 months
- Christopher John Kenney - $670K in XENE purchases and sales in the last 12 months
- Steven Gannon - $641K in XENE purchases and sales in the last 12 months
- Thomas Patrick Kelly - $560K in XENE purchases and sales in the last 12 months
- Andrea Difabio - $231K in XENE purchases and sales in the last 12 months
- Gary Patou - $70K in XENE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Sherry Aulin?
Sherry Aulin is a corporate insider, tracked as Chief Financial Officer of Xenon Pharmaceuticals Inc. (XENE). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Sherry Aulin last file a Form 4?
The only primary Form 4 on record is dated 19 December 2024.
Has Sherry Aulin been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($771K) across all tracked filings.
